Piperacillin

CHEMBL702 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

517.6 g/mol

LogP

0.5

Phase

4

A broad-spectrum penicillin-type antibiotic used to treat serious bacterial infections including pneumonia, urinary tract infections, and skin infections, often combined with another medication called tazobactam to prevent bacterial resistance. It is typically given intravenously in hospital settings for severe infections.

Moleküler Ağırlık

517,6000 g/mol

LogP

0,50

TPSA

182,00 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Pancreatic Cancer Cardiovascular Disease Age-Related Macular Degeneration Pain Management Asthma Chronic Obstructive Pulmonary Disease Epilepsy Migraine Schizophrenia Bipolar Disorder Generalized Anxiety Disorder Insomnia Infectious Disease Chronic Kidney Disease Deep Vein Thrombosis / Pulmonary Embolism Obesity Lymphoma Hypertension Chronic Pain Heart Failure Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c2ccccc2)C(=O)C1=O

InChI

InChI=1S/C23H27N5O7S/c1-4-26-10-11-27(19(32)18(26)31)22(35)25-13(12-8-6-5-7-9-12)16(29)24-14-17(30)28-15(21(33)34)23(2,3)36-20(14)28/h5-9,13-15,20H,4,10-11H2,1-3H3,(H,24,29)(H,25,35)(H,33,34)/t13-,14-,15+,20-/m1/s1

Molecular Formula

C23H27N5O7S

HBD / HBA

3 / 8

Döndürülebilir Bağlar

6

Ağır Atomlar

36

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A broad-spectrum penicillin-type antibiotic used to treat serious bacterial infections including pneumonia, urinary tract infections, and skin infections, often combined with another medication called tazobactam to prevent bacterial resistance. It is typically given intravenously in hospital settings for severe infections.

Yes, Piperacillin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL702. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 43672. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Piperacillin PillFYI'da

Yapı

Hızlı Veriler

Formül: C23H27N5O7S
Eş Anlamlılar: 5

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.